Schrödinger (SDGR) Reports $256M Revenue and 10-15% ACV Growth
Published on · Source: finance.yahoo.com
AI Summary
Summarized by AI from the source belowSchrödinger (SDGR) generated $256 million in total revenue for 2025, with $200 million attributed to software revenue and an annual contract value (ACV) of $198 million. The company anticipates ACV growth of 10% to 15% in 2026, projecting an ACV range of $218 million to $228 million. Management highlighted that existing cash reserves support operations well into the journey toward positive adjusted EBITDA by the end of 2028. Schrödinger focuses on drug discovery and has a solid balance sheet, enhancing its position in the biotech sector amidst an improving macro environment.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
Get stories like this as they break
Our Telegram channel posts every market story the moment it is published. Free, and you can mute or leave anytime.
